<?xml version="1.0" encoding="UTF-8"?>
<xml>
<records>
<record>
  <contributors>
    <authors>
      <author>Barrachina Porcar, Laura</author>
      <author>Remacha Gayán, Ana Rosa</author>
      <author>Romero Lasheras, Antonio</author>
      <author>Vázquez Bringas, Francisco José</author>
      <author>Albareda, Jorge</author>
      <author>Prades, Marta</author>
      <author>Gosálvez, Jaime</author>
      <author>Roy, Rosa</author>
      <author>Zaragoza, Pilar</author>
      <author>Martín Burriel, Inmaculada</author>
      <author>Rodellar Penella, Clementina</author>
    </authors>
  </contributors>
  <titles>
    <title>Priming equine bone marrow derived mesenchymal stem cells (eBM-MSCs) with pro-inflammatory cytokines: implications in immunomodulation-immunogenicity balance, cell viability and differentiation potential</title>
    <secondary-title>Stem Cells Dev.</secondary-title>
  </titles>
  <doi>10.1089/scd.2016.0209</doi>
  <pages/>
  <volume/>
  <number/>
  <dates>
    <year>2017</year>
    <pub-dates>
      <date>2017</date>
    </pub-dates>
  </dates>
  <abstract/>
</record>

</records>
</xml>